Biotech
The Childhood Brain Cancer That Kills Every Patient Just Met a $116M CAR-T
BrainChild Bio raised $116M to run the pivotal trial for BCB-276, a CAR-T that pushed DIPG survival from ~11 to 19.8 months in a cancer that has beaten every drug for 50 years.